To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Ampersand invests in Magritek
Ampersand Capital Partners has made a minority investment in New Zealand-based Magritek, a provider of benchtop and portable NMR instruments for life sciences and other industries.
